Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a trial of OAB-14 dry suspension in Alzheimer's disease
CTR20251920Phase 2Active
- Sponsor
- 山东新华制药股份有限公司
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OAB-14 in Alzheimer's disease (AD), sponsored by 山东新华制药股份有限公司. Started Jun 2025; status: active.
02
Drugs
OAB-14
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20251920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251920.